Diabetes & Metabolism Journal

Original Article

Others
Serum Magnesium Levels Are Negatively Associated with Obesity and Abdominal Obesity in Type 2 Diabetes Mellitus: A Real-World Study: Man-Rong Xu, Ai-Ping Wang, Yu-Jie Wang, Jun-Xi Lu, Li Shen, Lian-Xi Li; Diabetes Metab J. 2024;48(6):1147-1159. Published online May 29, 2024; DOI: https://doi.org/10.4093/dmj.2023.0401

10,158 View
290 Download
6 Web of Science
6 Crossref

Abstract PDF Supplementary Material PubReader ePub

Background
There remains controversy over the relationship between serum magnesium levels and obesity in type 2 diabetes mellitus (T2DM). Therefore, the aim of this study was to assess whether there is any association of serum magnesium levels with obesity and abdominal obesity in T2DM.
Methods
This cross-sectional, real-world study was conducted in 8,010 patients with T2DM, which were stratified into quintiles according to serum magnesium levels. The clinical characteristics and the prevalence of obesity and abdominal obesity were compared across serum magnesium quintiles in T2DM. Regression analyses were used to evaluate the relationship of serum magnesium with obesity and abdominal obesity in T2DM (clinical trial registration number: ChiCTR1800015893).
Results
After adjustment for age, sex, and duration of diabetes, the prevalence of obesity and abdominal obesity was significantly declined across magnesium quintiles (obesity: 51.3%, 50.8%, 48.9%, 45.3%, and 43.8%, respectively, P<0.001 for trend; abdominal obesity: 71.5%, 70.5%, 68.2%, 66.4%, and 64.5%, respectively, P=0.001 for trend). After controlling for confounders, there were clearly negative associations of serum magnesium levels and quintiles with obesity and abdominal obesity in T2DM. Moreover, C-reactive protein partly mediates the effect of serum magnesium on obesity and abdominal obesity (P=0.016 and P=0.004, respectively).
Conclusion
The significantly negative relationship between serum magnesium and the risk of obesity and abdominal obesity was observed in T2DM. Furthermore, the independently negative association of serum magnesium with obesity may be explained by its anti-inflammatory functions. Serum magnesium levels may be applied to assess the risk of obesity and abdominal obesity in T2DM.

Citations

Citations to this article as recorded by

High estradiol/testosterone ratio increased the risk of metabolic dysfunction‐associated steatotic liver disease in men with type 2 diabetes mellitus
Meng‐Han Li, Jun‐Wei Wang, Man‐Rong Xu, Ya‐Wen Zhang, Lian‐Xi Li
Journal of Diabetes Investigation.2026; 17(1): 129. CrossRef
Assessing the Impact of Dietary Calcium–Magnesium Ratio on Calciotrophic Hormones and Body Composition Using Validated Food Frequency Questionnaires
Emad Aldeen Alsayed, Patricia A. Shewokis, Jennifer Nasser, Deeptha Sukumar
Dietetics.2026; 5(1): 7. CrossRef
Electrolyte Imbalances and Metabolic Emergencies in Obesity: Mechanisms and Clinical Implications
Iulia Najette Crintea, Alexandru Cristian Cindrea, Ovidiu Alexandru Mederle, Cosmin Iosif Trebuian, Romulus Timar
Diseases.2025; 13(3): 69. CrossRef
The association between body roundness index and osteoporosis in older patients: a cross-sectional study based on a comprehensive geriatric assessment
Lingwei Li, Yucen Ma, Xinyi He, Mengyu Cao, Enlai Zheng, Jiyan Leng
BMC Geriatrics.2025;[Epub] CrossRef
Physiological role of magnesium in the animal body: biochemical mechanisms and clinical significance
V. O. Danchuk, V. I. Karpovskyi, O. V. Danchuk, V. V. Danchuk, M. G. Chesak, B. V. Gutyj, P. V. Karpovskyi, V. V. Karpovskyi, V. B. Todoriuk
Scientific Messenger of LNU of Veterinary Medicine and Biotechnologies.2025; 27(119): 185. CrossRef
Magnesium Matters: A Comprehensive Review of Its Vital Role in Health and Diseases
Ghizal Fatima, Andrej Dzupina, Hekmat B Alhmadi, Aminat Magomedova, Zainab Siddiqui, Ammar Mehdi, Najah Hadi
Cureus.2024;[Epub] CrossRef

First
Prev
Page of 1
Next
Last

Search